France· FR:65236258
IZINOVA, solution à diluer pour solution buvable
A medicinal product containing sulfate de potassium + sulfate de sodium anhydre + sulfate de magnésium heptahydraté, registered in France by MAYOLY PHARMA FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SULFATE DE POTASSIUM + SULFATE DE SODIUM ANHYDRE + SULFATE DE MAGNÉSIUM HEPTAHYDRATÉ
- Manufacturer
- MAYOLY PHARMA FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009269952492 flacon(s) polytéréphtalate (PET) de 176 ml avec fermeture de sécurité enfant avec gobelet(s) doseur(s) polypropylèneEUR 7.62
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sulfate de potassium + sulfate de sodium anhydre + sulfate de magnésium heptahydraté in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f9ba6c6f-790d-42cf-8bfc-70bcad6fdb03 GET /v1/drugs/f9ba6c6f-790d-42cf-8bfc-70bcad6fdb03?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65236258",
"date_amm": "2013-04-26",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "SULFATE DE POTASSIUM + SULFATE DE SODIUM ANHYDRE + SULFATE DE MAGNÉSIUM HEPTAHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution à diluer pour solution buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about sulfate de potassium + sulfate de sodium anhydre + sulfate de magnésium heptahydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.